CODEXIS INC. - COMMON STOCK
4.9100
24-January-25 16:45:00
15 minutes delayed
Stocks
-0.0700
-1.41%
Today's range
4.8800 - 5.1600
ISIN
N/A
Source
NASDAQ
-
26 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis to Report Second Quarter 2021 Financial Results on August 5
22 Jul 2021 16:05:01 By Nasdaq GlobeNewswire
-
14 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Earns Milestone Payment from GlaxoSmithKline
07 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
17 Jun 2021 16:44:08 By Nasdaq GlobeNewswire
-
10 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Codexis to Participate in Upcoming Virtual Healthcare Conferences
25 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis to Participate in Upcoming Virtual Healthcare Conferences
17 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Reports First Quarter 2021 Financial Results
06 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
Codexis to Report First Quarter 2021 Financial Results on May 6
22 Apr 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results
25 Feb 2021 16:05:03 By Nasdaq GlobeNewswire
-
Codexis to Present at Upcoming Virtual Healthcare Conferences
18 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
-
Codexis to Report Fourth Quarter and Full Year 2020 Results on February 25
11 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth
09 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
03 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
-
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production
13 Jan 2021 07:00:00 By Nasdaq GlobeNewswire
-
Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference
05 Jan 2021 07:00:00 By Nasdaq GlobeNewswire